Key result
Physiologist-led cardio-oncology echo clinics identify cardiac abnormalities requiring referral in up to 35% of cancer survivors.
Why the study?
With the expansion of specialized cardio-oncology services, the demand for echocardiography in patients with active cancer or in remission continues to grow.
Optimising cardio-oncology echocardiography services through physiologist-led clinics and integrated one-stop models improves service delivery and reduces the burden of healthcare visits for cancer patients.
Answers are grounded in this paper and cite their sources.
Optimised echo delivery may reduce cancer patient visits while accelerating cardio-toxicity detection; leaves open multicentre validation before adoption.
Echocardiography plays a central role in the cardiovascular assessment and surveillance of patients with active cancer or in remission. With the development of specialised cardio-oncology services, the demand for echocardiography in cancer patients continues to grow. Here we explain the nuances of echocardiography in cardio-oncology, and detail how our institution has optimised service delivery to minimise cancer patient healthcare visits, improve time to cardio-toxicity diagnosis and utilising physiologists to lead cancer survivorship clinics.
No takes yet. Share an insight, caveat, or question.
Lushington et al. (2026) conducted a review in Cancer (n=141). Physiologist-led cardio-oncology echocardiography service was evaluated. A physiologist-led cardio-oncology echocardiography service integrated into cancer clinics identified cardiac abnormalities requiring referral in 10% of lymphoma patients and 35% of late-effects cancer survivors.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: